ARTICLE | Company News

Epogin rebuffed for cancer indication

June 13, 2011 11:56 PM UTC

A committee within Japan's Ministry of Health, Labor, and Welfare recommended against expanding the indication for Epogin epoetin beta from Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) to include chemotherapy-induced anemia. The erythropoiesis-stimulating agent (ESA) is already approved to treat anemia associated with chronic kidney disease (CKD) and for use in autologous blood transfusions. ...